Chinese biopharma firm Antengene seeks Hong Kong listing

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Chinese biopharma firm Antengene seeks Hong Kong listing

Jonathan Breen
August 28, 2020 08:30 AM
pills adobe stock 575x375 pharmaceuticals
Heap of medical pills in white, blue and other colors. Pills in plastic package. Panoramic banner for design. | OKSANA KAZYKINA/okskaz - stock.adobe.com

Antengene Corp, a clinical stage biopharmaceutical company, has set the ball rolling for a Hong Kong IPO, adding to a bulging pipeline of healthcare firms targeting the city’s bourse.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP MorganEquity IPOsHealth and BiotechEquityChinaHong Kong SARAsiaGreater ChinaNortheast AsiaAsia PacificEmerging MarketsSRIGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article